卵巣がん治療薬市場：がんタイプ別、治療タイプ別、投与経路別、エンドユーザー別& 2024～2032年予測

卵巣がん治療薬市場規模は、個別化医療動向の影響力の高まりにより、2024年から2032年にかけてCAGR 6.3%を記録する見通しです。

遺伝子プロファイリングとバイオマーカー探索の進歩により、カスタマイズされた医薬品の開発が促進され、患者の予後改善につながります。さらに、医療技術や診断法の改善により、革新的でより効果的な卵巣がん治療薬の開発が進んでいます。例えば、2022年11月、イミュノジェン社は、進行卵巣がんを治療するための医薬品Elahereについて、初のFDA認可を取得しました。

さらに、製薬企業、研究機関、ヘルスケア組織間の協力関係の高まりは、卵巣がん治療薬の開発を加速させ、業界の成長に拍車をかけています。例えば、2023年6月、USask（サスカチュワン大学）の婦人科がんの専門家と病理学の専門家が共同で、卵巣がん患者の腫瘍を調べ、新しいクラスの薬への反応性を示す様々な変異を調べた。

卵巣がん治療薬市場は、がん種、治療タイプ、投与経路、エンドユーザー、地域に区分されます。

治療タイプ別では、化学療法分野の市場シェアが2024年から2032年の間にCAGR 6.7%を記録すると見られています。化学療法は、卵巣がんの初回治療と再発治療において極めて重要な役割を果たすため、卵巣がんの治療法として注目されています。化学療法レジメンの強化、新規薬剤の併用、治療成績の改善と生存率の延長を目的とした標的治療などの研究開発努力が続けられていることも、このセグメントの拡大を支えています。

エンドユーザー別では、卵巣がん治療薬産業は2023年に小売薬局セグメントから大きな売上を記録し、2024年から2032年までのCAGRは6.2%と推定されます。この成長は、卵巣がん治療薬へのアクセスだけでなく、患者への利便性の向上における小売薬局の台頭によるものです。さらに、ヘルスケア部門における認識と教育イニシアチブの高まりが、同分野の成長をさらに促進すると思われます。

地域別では、アジア太平洋地域の卵巣がん治療薬産業は、2024-2032年の間にCAGR 6.6%で力強い成長を示すと見られています。これは、卵巣がんの罹患率の上昇、認知度の向上、ヘルスケア・インフラの整備に起因しています。例えば、2023年に発表されたNCBIの統計によると、APACの女性の卵巣がん罹患率は10万人当たり9.2人です。同地域では早期発見と高度な治療オプションが重視されるようになっていることも、卵巣がん治療薬の需要を押し上げています。さらに、政策、臨床研究、新規治療薬の利用可能性は、地域市場の拡大をさらに加速させると見込まれています。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 卵巣がん治療薬市場の洞察

• 業界情勢
• 業界への影響要因
  • 促進要因
    • 卵巣がん罹患率の上昇
    • 研究開発活動への投資の増加
    • 卵巣がんの新規治療に対する需要の増加
    • 意識の高まりと早期発見
  • 業界の潜在的リスク＆課題
    • 治療に伴う副作用
• 成長の可能性分析
  • がんタイプ別
  • 治療タイプ別
  • 投与経路別
  • エンドユーザー別
• 規制状況
• パイプライン分析
• ポーター分析
• PESTEL分析

第4章 競合情勢

• イントロダクション
• 企業マトリックス分析
• 主要市場プレーヤーの競合分析
• 競合のポジショニングマトリックス
• 戦略ダッシュボード

第5章 卵巣がん治療薬市場推定・主要動向予測：がんタイプ別、2018年～2032年

• 主要動向：がんタイプ別
• 上皮性卵巣がん
• 間質腫瘍
• 胚細胞腫瘍

第6章 卵巣がん治療薬市場推定・予測：治療タイプ別、2018年～2032年

• 主要動向：治療タイプ別
• 標的治療薬
  • PARP阻害薬
  • 血管新生阻害薬
  • その他の標的治療薬
• 免疫療法薬
• 化学療法薬
• ホルモン療法薬
• 放射線療法

第7章 卵巣がん治療薬市場推計・予測：投与経路別、2018年～2032年

• 主要動向：投与経路別
• 経口
• 静脈内
• 腹腔内

第8章 卵巣がん治療薬市場推定・予測：エンドユーザー別、2018-2032年

• 主要動向：エンドユーザー別
• 病院薬局
• 小売薬局
• その他のエンドユーザー

第9章 卵巣がん治療薬市場推定・予測：地域別、2018年～2032年

• 主要動向：地域別
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • その他中東とアフリカ

第10章 企業プロファイル

• F. Hoffmann-La Roche AG
• GlaxoSmithKline Plc.
• Immunogen Inc.
• Astrazeneca
• Merck KGaA
• Oasmia Pharmaceutical AB
• Clovis Oncology, Inc.
• Novartis AG
• Bristol-Myers Squibb Company
• Pfizer Inc.
• Eli Lilly and Company
• Aravive Biologics
• Allarity Therapeutics

Data Tables

• TABLE 1 Market revenue, by cancer type (2023)
• TABLE 2 Market revenue, by treatment type (2023)
• TABLE 3 Market revenue, by route of administration (2023)
• TABLE 4 Market revenue, by end-user (2023)
• TABLE 5 Market share, by region (2023)
• TABLE 6 Global ovarian cancer treatment drugs market size, by region, 2018 - 2023 (USD Million)
• TABLE 7 Global ovarian cancer treatment drugs market size, by region, 2024 - 2032 (USD Million)
• TABLE 8 Global ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 9 Global ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 10 Global ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 11 Global ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 12 Global ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 13 Global ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 14 Global ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 15 Global ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 16 Industry impact forces
• TABLE 17 Epithelial ovarian cancer market, 2018 - 2023 (USD Million)
• TABLE 18 Epithelial ovarian cancer market, 2024 - 2032 (USD Million)
• TABLE 19 Stromal tumors market, 2018 - 2023 (USD Million)
• TABLE 20 Stromal tumors market, 2024 - 2032 (USD Million)
• TABLE 21 Germ cell tumors market, 2018 - 2023 (USD Million)
• TABLE 22 Germ cell tumors market, 2024 - 2032 (USD Million)
• TABLE 23 Targeted therapy drugs market, 2018 - 2023 (USD Million)
• TABLE 24 Targeted therapy drugs market, 2024 - 2032 (USD Million)
• TABLE 25 PARP inhibitors market, 2018 - 2023 (USD Million)
• TABLE 26 PARP inhibitors market, 2024 - 2032 (USD Million)
• TABLE 27 Angiogenesis inhibitors market, 2018 - 2023 (USD Million)
• TABLE 28 Angiogenesis inhibitors market, 2024 - 2032 (USD Million)
• TABLE 29 Other targeted therapy drugs market, 2018 - 2023 (USD Million)
• TABLE 30 Other targeted therapy drugs market, 2024 - 2032 (USD Million)
• TABLE 31 Immunotherapy drugs market, 2018 - 2023 (USD Million)
• TABLE 32 Immunotherapy drugs market, 2024 - 2032 (USD Million)
• TABLE 33 Chemotherapy drugs market, 2018 - 2023 (USD Million)
• TABLE 34 Chemotherapy drugs market, 2024 - 2032 (USD Million)
• TABLE 35 Hormone therapy drugs market, 2018 - 2023 (USD Million)
• TABLE 36 Hormone therapy drugs market, 2024 - 2032 (USD Million)
• TABLE 37 Radiation therapy market, 2018 - 2023 (USD Million)
• TABLE 38 Radiation therapy market, 2024 - 2032 (USD Million)
• TABLE 39 Oral market, 2018 - 2023 (USD Million)
• TABLE 40 Oral market, 2018 - 2023 (USD Million)
• TABLE 41 Intravenous market, 2018 - 2023 (USD Million)
• TABLE 42 Intravenous market, 2024 - 2032 (USD Million)
• TABLE 43 Intraperitoneal market, 2018 - 2023 (USD Million)
• TABLE 44 Intraperitoneal market, 2024 - 2032 (USD Million)
• TABLE 45 Hospital pharmacies market, 2018 - 2023 (USD Million)
• TABLE 46 Hospital pharmacies market, 2024 - 2032 (USD Million)
• TABLE 47 Retail pharmacies market, 2018 - 2023 (USD Million)
• TABLE 48 Retail pharmacies market, 2024 - 2032 (USD Million)
• TABLE 49 Other end-users market, 2018 - 2023 (USD Million)
• TABLE 50 Other end-users market, 2024 - 2032 (USD Million)
• TABLE 51 North America ovarian cancer treatment drugs market size, by country, 2018 - 2023 (USD Million)
• TABLE 52 North America ovarian cancer treatment drugs market size, by country, 2024 - 2032 (USD Million)
• TABLE 53 North America ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 54 North America ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 55 North America ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 56 North America ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 57 North America ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 58 North America ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 59 North America ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 60 North America ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 61 North America ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 62 North America ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 63 U.S. ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 64 U.S. ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 65 U.S. ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 66 U.S. ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 67 U.S ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 68 U.S ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 69 U.S. ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 70 U.S. ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 71 U.S. ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 72 U.S. ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 73 Canada ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 74 Canada ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 75 Canada ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 76 Canada ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 77 Canada ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 78 Canada ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 79 Canada ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 80 Canada ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 81 Canada ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 82 Canada ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 83 Europe ovarian cancer treatment drugs market size, by country, 2018 - 2023 (USD Million)
• TABLE 84 Europe ovarian cancer treatment drugs market size, by country, 2024 - 2032 (USD Million)
• TABLE 85 Europe ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 86 Europe ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 87 Europe ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 88 Europe ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 89 Europe ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 90 Europe ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 91 Europe ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 92 Europe ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 93 Europe ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 94 Europe ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 95 Germany ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 96 Germany ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 97 Germany ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 98 Germany ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 99 Germany ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 100 Germany ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 101 Germany ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 102 Germany ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 103 Germany ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 104 Germany ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 105 UK ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 106 UK ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 107 UK ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 108 UK ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 109 UK ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 110 UK ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 111 UK ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 112 UK ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 113 UK ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 114 UK ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 115 France ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 116 France ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 117 France ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 118 France ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 119 France ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 120 France ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 121 France ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 122 France ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 123 France ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 124 France ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 125 Spain ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 126 Spain ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 127 Spain ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 128 Spain ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 129 Spain ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 130 Spain ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 131 Spain ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 132 Spain ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million
• TABLE 133 Spain ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 134 Spain ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 135 Italy ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 136 Italy ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 137 Italy ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 138 Italy ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 139 Italy ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 140 Italy ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 141 Italy ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 142 Italy ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 143 Italy ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 144 Italy ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 145 Rest of Europe ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 146 Rest of Europe ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 147 Rest of Europe ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 148 Rest of Europe ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 149 Rest of Europe ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 150 Rest of Europe ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 151 Rest of Europe ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 152 Rest of Europe ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 153 Rest of Europe ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 154 Rest of Europe ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 155 Asia Pacific ovarian cancer treatment drugs market size, by country, 2018 - 2023 (USD Million)
• TABLE 156 Asia Pacific ovarian cancer treatment drugs market size, by country, 2024 - 2032 (USD Million)
• TABLE 157 Asia Pacific ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 158 Asia Pacific ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 159 Asia Pacific ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 160 Asia Pacific ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 161 Asia Pacific ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 162 Asia Pacific ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 163 Asia Pacific ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 164 Asia Pacific ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 165 Asia Pacific ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 166 Asia Pacific ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 167 China ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 168 China ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 169 China ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 170 China ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 171 China ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 172 China ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 173 China ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 174 China ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 175 China ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 176 China ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 177 Japan ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 178 Japan ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 179 Japan ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 180 Japan ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 181 Japan ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 182 Japan ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 183 Japan ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 184 Japan ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 185 Japan ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 186 Japan ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 187 India ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 188 India ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 189 India ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 190 India ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 191 India ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 192 India ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 193 India ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 194 India ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 195 India ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 196 India ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 197 Australia ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 198 Australia ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 199 Australia ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 200 Australia ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 201 Australia ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 202 Australia ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 203 Australia ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 204 Australia ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 205 Australia ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 206 Australia ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 207 Rest of Asia Pacific ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 208 Rest of Asia Pacific ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 209 Rest of Asia Pacific ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 210 Rest of Asia Pacific ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 211 Rest of Asia Pacific ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 212 Rest of Asia Pacific ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 213 Rest of Asia Pacific ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 214 Rest of Asia Pacific ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 215 Rest of Asia Pacific ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 216 Rest of Asia Pacific ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 217 Latin America ovarian cancer treatment drugs market size, by country, 2018 - 2023 (USD Million)
• TABLE 218 Latin America ovarian cancer treatment drugs market size, by country, 2024 - 2032 (USD Million)
• TABLE 219 Latin America ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 220 Latin America ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 221 Latin America ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 222 Latin America ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 223 Latin America ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 224 Latin America ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 225 Latin America ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 226 Latin America ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 227 Latin America ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 228 Latin America ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 229 Brazil ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 230 Brazil ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 231 Brazil ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 232 Brazil ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 233 Brazil ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 234 Brazil ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 235 Brazil ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 236 Brazil ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 237 Brazil ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 238 Brazil ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 239 Mexico ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 240 Mexico ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 241 Mexico ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 242 Mexico ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 243 Mexico ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 244 Mexico ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 245 Mexico ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 246 Mexico ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 247 Mexico ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 248 Mexico ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 249 Rest of Latin America ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 250 Rest of Latin America ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 251 Rest of Latin America ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 252 Rest of Latin America ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 253 Rest of Latin America ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 254 Rest of Latin America ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 255 Rest of Latin America ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 256 Rest of Latin America ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 257 Rest of Latin America ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 258 Rest of Latin America ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 259 Middle East & Africa ovarian cancer treatment drugs market size, by country, 2018 - 2023 (USD Million)
• TABLE 260 Middle East & Africa ovarian cancer treatment drugs market size, by country, 2024 - 2032 (USD Million)
• TABLE 261 Middle East & Africa ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 262 Middle East & Africa ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 263 Middle East & Africa ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 264 Middle East & Africa ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 265 Middle East & Africa ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 266 Middle East & Africa ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 267 Middle East & Africa ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 268 Middle East & Africa ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 269 Middle East & Africa ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 270 Middle East & Africa ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 271 South Africa ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 272 South Africa ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 273 South Africa ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 274 South Africa ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 275 South Africa ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 276 South Africa ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 277 South Africa ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 278 South Africa ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 279 South Africa ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 280 South Africa ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 281 Saudi Arabia ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 282 Saudi Arabia ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 283 Saudi Arabia ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 284 Saudi Arabia ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 285 Saudi Arabia ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 286 Saudi Arabia ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 287 Saudi Arabia ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 288 Saudi Arabia ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million
• TABLE 289 Saudi Arabia ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 290 Saudi Arabia ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)
• TABLE 291 Rest of Middle East & Africa ovarian cancer treatment drugs market size, by cancer type, 2018 - 2023 (USD Million)
• TABLE 292 Rest of Middle East & Africa ovarian cancer treatment drugs market size, by cancer type, 2024 - 2032 (USD Million)
• TABLE 293 Rest of Middle East & Africa ovarian cancer treatment drugs market size, by treatment type, 2018 - 2023 (USD Million)
• TABLE 294 Rest of Middle East & Africa ovarian cancer treatment drugs market size, by treatment type, 2024 - 2032 (USD Million)
• TABLE 295 Rest of Middle East & Africa ovarian cancer treatment drugs market size, by targeted therapy drugs, 2018 - 2023 (USD Million)
• TABLE 296 Rest of Middle East & Africa ovarian cancer treatment drugs market size, by targeted therapy drugs, 2024 - 2032 (USD Million)
• TABLE 297 Rest of Middle East & Africa ovarian cancer treatment drugs market size, by route of administration, 2024 - 2032 (USD Million)
• TABLE 298 Rest of Middle East & Africa ovarian cancer treatment drugs market size, by route of administration, 2018 - 2023 (USD Million)
• TABLE 299 Rest of Middle East & Africa ovarian cancer treatment drugs market size, by end-user, 2018 - 2023 (USD Million)
• TABLE 300 Rest of Middle East & Africa ovarian cancer treatment drugs market size, by end-user, 2024 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Ovarian cancer treatment drugs industry 360 degree synopsis, 2018 - 2032
• FIG 7 Industry landscapeanalysis, 2018 - 2032 (USD Million)
• FIG 8 Growth potentialanalysis, by cancer type
• FIG 9 Growth potentialanalysis, by treatment type
• FIG 10 Growth potentialanalysis, by route of administration
• FIG 11 Growth potentialanalysis, by end-user
• FIG 12 Porter'sanalysis
• FIG 13 PESTELanalysis
• FIG 14 Company matrixanalysis, 2023
• FIG 15 Competitiveanalysis of major market players, 2023
• FIG 16 Competitive positioning matrix, 2023
• FIG 17 Strategic dashboard, 2023

Ovarian Cancer Treatment Drugs Market size is poised to depict 6.3% CAGR between 2024 and 2032 owing to the increasing influence of personalized medicine trends. Advances in genetic profiling and biomarker discovery are facilitating the creation of customized medicines, leading to better patient outcomes. Additionally, improvements in medical technology and diagnostics have led to the development of innovative and more effective ovarian cancer treatment medications. For instance, in November 2022, ImmunoGen earned its first FDA clearance for its medicine, Elahere, to treat advanced ovarian cancer.

Furthermore, the rising collaborations between pharmaceutical corporations, research institutes, and healthcare organizations are accelerating the development of ovarian cancer treatment drugs, adding to the industry growth. For instance, in June 2023, USask (University of Saskatchewan) gynecologic cancer specialists and pathology specialists collaborated to examine the tumors of ovarian cancer patients for a variety of mutations that indicate responsiveness to a new class of medications.

The ovarian cancer treatment drugs market is segmented into cancer type, treatment type, route of administration, end-user, and region.

Based on treatment type, the market share from the chemotherapy segment is likely to witness 6.7% CAGR between 2024 and 2032. Chemotherapy has emerged as a preferred ovarian cancer treatment as it plays a pivotal role in both first-line and recurrent ovarian cancer cases. The ongoing R&D efforts to enhance chemotherapy regimens, novel drug combinations, and targeted therapies for offering improved outcomes and extended survival rates will also support the segment expansion.

In terms of end-user, the ovarian cancer treatment drugs industry recorded significant sales from the retail pharmacies segment in 2023 and is estimated to depict a 6.2% CAGR from 2024 to 2032. The growth can be attributed to the rising prominence of retail pharmacies in offering enhanced convenience to patients as well as accessibility to essential ovarian cancer treatment drugs. Additionally, the growing awareness and education initiatives in the healthcare sector will further drive the segment growth.

Regionally, the Asia Pacific ovarian cancer treatment drugs industry is set to exhibit robust growth at 6.6% CAGR during 2024-2032, attributed to the escalating incidences of ovarian cancer, rising awareness, and the presence of improved healthcare infrastructure. For instance, according to NCBI statistics released in 2023, the rate of ovarian cancer among APAC women is 9.2 per 100,000. The growing emphasis on early detection and advanced treatment options in the region is also propelling the demand for ovarian cancer treatment drugs. Additionally, government initiatives, clinical research, and the availability of novel therapeutics will further accelerate the regional market expansion.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Data validation
• 1.5 Data sources
  • 1.5.1 Primary
  • 1.5.2 Secondary
    • 1.5.2.1 Paid sources
    • 1.5.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Ovarian cancer treatment drugs industry 360 degree synopsis, 2018 - 2032 (USD Million)
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Cancer type trends
  • 2.1.4 Treatment type trends
  • 2.1.5 Route of administration trends
  • 2.1.6 End-user trends

Chapter 3 Ovarian Cancer Treatment Drugs Market Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidence of ovarian cancer
    • 3.2.1.2 Increasing investments in R&D activities
    • 3.2.1.3 Increasing demand for novel treatment for ovarian cancer
    • 3.2.1.4 Growing awareness and early detection
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Adverse effects associated with the treatment
• 3.3 Growth potentialanalysis
  • 3.3.1 By cancer type
  • 3.3.2 By treatment type
  • 3.3.3 By route of administration
  • 3.3.4 By end-user
• 3.4 Regulatory landscape
• 3.5 Pipelineanalysis
• 3.6 Porter'sanalysis
• 3.7 PESTELanalysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrixanalysis, 2023
• 4.3 Competitiveanalysis of major market players, 2023
• 4.4 Competitive positioning matrix, 2023
• 4.5 Strategic dashboard, 2023

Chapter 5 Ovarian Cancer Treatment Drugs Market Estimates and Forecast, By Cancer Type, 2018-2032 (USD Million)

• 5.1 Key trends, by cancer type
• 5.2 Epithelial ovarian cancer
• 5.3 Stromal tumors
• 5.4 Germ cell tumors

Chapter 6 Ovarian Cancer Treatment Drugs Market Estimates and Forecast, By Treatment Type, 2018-2032 (USD Million)

• 6.1 Key trends, by treatment type
• 6.2 Targeted therapy drugs
  • 6.2.1 PARP inhibitors
  • 6.2.2 Angiogenesis inhibitors
  • 6.2.3 Other targeted therapy drugs
• 6.3 Immunotherapy drugs
• 6.4 Chemotherapy drugs
• 6.5 Hormone therapy drugs
• 6.6 Radiation therapy

Chapter 7 Ovarian Cancer Treatment Drugs Market Estimates and Forecast, By Route of Administration, 2018-2032 (USD Million)

• 7.1 Key trends, by route of administration
• 7.2 Oral
• 7.3 Intravenous
• 7.4 Intraperitoneal

Chapter 8 Ovarian Cancer Treatment Drugs Market Estimates and Forecast, By End-user, 2018-2032 (USD Million)

• 8.1 Key trends, by end-user
• 8.2 Hospital pharmacies
• 8.3 Retail pharmacies
• 8.4 Other end-users

Chapter 9 Ovarian Cancer Treatment Drugs Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

• 9.1 Key trends, by region
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 Middle East & Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

• 10.1 F. Hoffmann-La Roche AG
• 10.2 GlaxoSmithKline Plc.
• 10.3 Immunogen Inc.
• 10.4 Astrazeneca
• 10.5 Merck KGaA
• 10.6 Oasmia Pharmaceutical AB
• 10.7 Clovis Oncology, Inc.
• 10.8 Novartis AG
• 10.9 Bristol-Myers Squibb Company
• 10.10 Pfizer Inc.
• 10.11 Eli Lilly and Company
• 10.12 Aravive Biologics
• 10.13 Allarity Therapeutics